Clinical Trial

A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to assess the concentrations of nipocalimab (pharmacokinetics \[PK\]) in the breast milk after administration of a single dose of nipocalimab into the vein, in healthy lactating women.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-07
Trial Details
NCT Number NCT07669077
Lead Sponsor Janssen Research & Development, LLC
Conditions Healthy
Enrollment 8 participants
Start Date 2026-06-26
Primary Completion 2027-02-16 (estimated)
Study Completion 2027-02-16 (estimated)
Updated on ClinicalTrials.gov 2026-07-06